Ilika plc Interims show solid-state progress – Zeus Capital

Ilika plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Ilika plc (LON:IKA) interims today show the company is executing its solid-state battery commercialisation strategy as planned. We leave FY17 & FY18 forecasts unchanged and look for first OEM licensing deals and associated up-front payments in the coming months. The very low leakage currents, high energy densities, extended life span and hot operation capability of Ilika’s, state-of-the-art, Stereax™ solid-state platform, compared to incumbent lithium ion technologies, open up lucrative, high-growth, miniaturized (1mm2), elevated temperature and energy harvesting sensor markets. Examples of such are internet of things (‘IoT’), bio-electronic, industrial and transport applications. Ilika is rightly focussing (c.75% of resource) on solid-state battery commercialisation. The remaining resource is focussed on core materials development contracts in other areas, including aerospace engine super-alloys, electronic materials, and lithium-sulphur batteries for scale storage, with BAE systems & GKN, Seagate and Johnson Matthey respectively.

* Interims in-line, solid-state battery commercialisation with OEM licensing partners in key target markets on track. In H117 Ilika has been progressing discussions with a selection of potential solid-sate battery commercialisation OEM partners, and we expect these to produce first OEM licencing deals in key application areas in the coming months. Initial up-front licensing payments, coupled with on-going materials development contract revenues, will drive the top line, and we currently leave FY17 and FY18 forecasts unchanged.

* Solid cash position. Ilika completed a successful net £5.8m equity fundraise in October, to provide balance sheet strength ahead of key OEM licensing negotiations. The company is debt free, and has a well-controlled sub-£4m annual cash burn, resulting in a healthy cash position of £7.1m at period end.

* The company is focussing on solid-sate battery commercialisation and has world-class technology capable of exploiting explosive growth mass markets. Ilika’s advanced Stereax™ solid-state battery platform enables OEM’s, device designers and system integrators to create differentiated products including ‘leave for life’, bio-compatible and high-temperature batteries for sensors at a time when markets for such technologies are exploding. Circa15 billion sensors for wireless networks were sold in 2015, constituting a 200% per annum growth rate. Ilika is gaining recognition as a world-leader in this rapidly evolving field.

* The company continues to run its core materials discovery and optimisation model. In addition to solid-state battery commercialisation, Ilika continues to run its core business model, performing rapid materials discovery and development programs with blue-chip clients in a number of high-tech fields. These include 2 contracts on super-alloys for aerospace engines; the first with Rolls Royce on improved thermal performance, and the second with GKN and BAE systems developing self-healing super-alloys suitable for mass production by 3D printing.

Commenting on the results Graeme Purdy, CEO of Ilika Plc, said: “In the first half of the year we have intensified commercial discussions with potential solid-state battery licensees, further strengthened our IP portfolio and augmented our materials discovery programmes.”

Share on:
Find more news, interviews, share price & company profile here for:

If our articles help you then why not add us as a preferred news source on Google.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Defence battery demand highlights strategic opening for Ilika

Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.

Ilika to showcase Stereax batteries to medical device manufacturers

Ilika’s Stereax batteries will be represented at Medical Technology Ireland 2026, giving the company direct exposure to medical device manufacturers and suppliers.

Ilika puts Stereax in front of medical device buyers

Ilika’s Stereax batteries will be represented at MEDevice Silicon Valley, putting the technology in front of medical device buyers and engineers.

Ilika to present solid-state battery progress at major UK energy storage conference

Ilika will present its Goliath quasi-solid-state cell technology at the Faraday Institution Conference 2026, giving investors a clear positioning update.

Search

Search